111 related articles for article (PubMed ID: 3166902)
1. Tumour response to chemotherapy in animals that have been treated with the same drugs prior to tumour implantation: a model for studying host effects on apparent drug resistance.
Luk CK; Tannock IF
Br J Cancer; 1988 Aug; 58(2):133-8. PubMed ID: 3166902
[TBL] [Abstract][Full Text] [Related]
2. Modification of tumour and host response to cyclophosphamide by misonidazole and by WR 2721.
Twentyman PR
Br J Cancer; 1981 Jun; 43(6):745-55. PubMed ID: 6264941
[TBL] [Abstract][Full Text] [Related]
3. Effect of misonidazole or metronidazole pretreatment on the response of the RIF-1 mouse sarcoma to melphalan, cyclophosphamide, chlorambucil and CCNU.
Twentyman P; Workman P
Br J Cancer; 1982 Mar; 45(3):447-55. PubMed ID: 7073938
[TBL] [Abstract][Full Text] [Related]
4. Development of drug resistance in a murine mammary tumour.
McMillan TJ; Stephens TC; Steel GG
Br J Cancer; 1985 Dec; 52(6):823-32. PubMed ID: 4074637
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of cyclophosphamide cytotoxicity in vivo by the benzamide analogue pyrazinamide.
Horsman MR; Chaplin DJ
Br J Cancer; 1994 Apr; 69(4):648-54. PubMed ID: 8142253
[TBL] [Abstract][Full Text] [Related]
6. Analysis of synergy between cyclophosphamide therapy and immunity against a mouse tumour.
Chassoux DM; Gotch FM; MacLennan IC
Br J Cancer; 1978 Aug; 38(2):211-8. PubMed ID: 698035
[TBL] [Abstract][Full Text] [Related]
7. In vivo therapeutic potential of combination thiol depletion and alkylating chemotherapy.
Siemann DW; Beyers KL
Br J Cancer; 1993 Dec; 68(6):1071-9. PubMed ID: 8260357
[TBL] [Abstract][Full Text] [Related]
8. Combinations of cyclophosphamide and misonidazole in the KHT sarcoma.
Siemann DW; Sutherland RM
Int J Radiat Oncol Biol Phys; 1982; 8(3-4):647-50. PubMed ID: 7107391
[No Abstract] [Full Text] [Related]
9. Enhancing effect of misonidazole on the response of the RIF-1 tumour to cyclophosphamide.
Law MP; Hirst DG; Brown JM
Br J Cancer; 1981 Aug; 44(2):208-18. PubMed ID: 7272187
[TBL] [Abstract][Full Text] [Related]
10. The effect of time between X-irradiation and chemotherapy on the growth of three solid mouse tumors--II. Cyclophosphamide.
Twentyman PR; Kallman RF; Brown JM
Int J Radiat Oncol Biol Phys; 1979 Sep; 5(9):1425-7. PubMed ID: 536251
[No Abstract] [Full Text] [Related]
11. Modification by WR 2721 of the response to chemotherapy of tumours and normal tissues in the mouse.
Twentyman PR
Br J Cancer; 1983 Jan; 47(1):57-63. PubMed ID: 6295428
[TBL] [Abstract][Full Text] [Related]
12. The effect of misonidazole combined with WR2721 on tumour response and leucopenia due to cyclophosphamide or melphalan.
McNally NJ
Br J Cancer; 1982 Oct; 46(4):670-4. PubMed ID: 6291565
[No Abstract] [Full Text] [Related]
13. Acute in vivo resistance in high-dose therapy.
Teicher BA; Ara G; Keyes SR; Herbst RS; Frei E
Clin Cancer Res; 1998 Feb; 4(2):483-91. PubMed ID: 9516940
[TBL] [Abstract][Full Text] [Related]
14. Chemosensitization by lipophilic nitroimidazoles.
Twentyman PR; Workman P
Br J Cancer; 1983 Jul; 48(1):17-26. PubMed ID: 6871076
[TBL] [Abstract][Full Text] [Related]
15. Response of an in vivo-in vitro tumour to X-rays and cytotoxic drugs: effect of tumour disaggregation method on cell survival.
Rasey JS; Nelson NJ
Br J Cancer Suppl; 1980 Apr; 4():217-21. PubMed ID: 6158976
[TBL] [Abstract][Full Text] [Related]
16. In vivo interaction of anti-cancer drugs with misonidazole or metronidazole: cyclophosphamide and BCNU.
Tannock IF
Br J Cancer; 1980 Dec; 42(6):871-80. PubMed ID: 7459221
[TBL] [Abstract][Full Text] [Related]
17. Host treatments affecting artificial pulmonary metastases: interpretation of loss of radioactively labelled cells from lungs.
Brown JM; Parker ET
Br J Cancer; 1979 Nov; 40(5):677-88. PubMed ID: 508577
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of the anti-tumour effect of cyclophosphamide by the bioreductive drugs AQ4N and tirapazamine.
Friery OP; Gallagher R; Murray MM; Hughes CM; Galligan ES; McIntyre IA; Patterson LH; Hirst DG; McKeown SR
Br J Cancer; 2000 Apr; 82(8):1469-73. PubMed ID: 10780528
[TBL] [Abstract][Full Text] [Related]
19. In vivo response of KHT sarcomas to combination chemotherapy with radiosensitizers and BCNU.
Mulcahy RT; Siemann DW; Sutherland RM
Br J Cancer; 1981 Jan; 43(1):93-9. PubMed ID: 7459244
[TBL] [Abstract][Full Text] [Related]
20. Effect of clinical levels of misonidazole on the response of tumour and normal tissues in the mouse to alkylating agents.
Brown JM; Hirst DG
Br J Cancer; 1982 May; 45(5):700-8. PubMed ID: 7082556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
